Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2011. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on specific share option exercises and sales.
Material Changes and Transactions
On December 8, 2011, Mr. M Dunoyer executed the following transactions under the GlaxoSmithKline Share Option Plan:
- Exercised options for 72,000 shares (granted Dec 3, 2002) at £11.79/share and sold them at £14.459/share.
- Exercised options for 67,329 shares (granted Dec 2, 2004) at £11.23/share and sold them at £14.435/share.
- Exercised options for 2,671 shares (granted Dec 2, 2004) at £11.23/share and sold them at £14.445/share.
- Exercised options for 70,000 shares (granted Dec 15, 2003) at £12.70/share and sold them at £14.441/share.
Total shares exercised and sold in this notification: 212,000.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory disclosure of insider trading activity.
Investor Verification Checklist
- Verify the total number of shares sold by Mr. M Dunoyer (212,000) against the company's insider trading registry.
- Confirm the exercise prices and sale prices listed to calculate the realized gain per share.
- Check subsequent filings for any additional transactions by Mr. Dunoyer or other PDMRs.
- Note that this filing does not contain quarterly or annual financial performance data.